Who are GRI Bio, Inc.'s main suppliers?

GRI Bio, Inc. (GRI) key suppliers include: H-C-WAINWRIGHT-CO-LLC. View the full supplier network at chainsifter.com/chain/GRI.

Who are GRI Bio, Inc.'s major customers?

GRI Bio, Inc. (GRI) key customers include: VALLON-PHARMACEUTICALS-INC. View the full customer network at chainsifter.com/chain/GRI.

What sector is GRI Bio, Inc. in?

GRI Bio, Inc. (GRI) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

GRI Bio, Inc. (GRI) Suppliers & Customers

1Suppliers

1Customers

3Debt Items

0Related Chains

Source-Backed Evidence Depth

GRI Bio, Inc. (GRI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

2Distinct source URLs

5High confidence

0.857Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

GRI Bio, Inc. Suppliers

Ticker	Name	Confidence	Evidence
H-C-WAINWRIGHT-CO-LLC	H-C-WAINWRIGHT-CO-LLC	92%	the Company entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC, pursuant to which the Company may from time to time issue and sell through Wainwright, acting as the Comp…

GRI Bio, Inc. Customers

Ticker	Name	Confidence	Evidence
VALLON-PHARMACEUTICALS-INC	VALLON-PHARMACEUTICALS-INC	62%	counts payable, accrued expenses and certain liability classified warrants. The carrying amounts reported in the consolidated balance sheets for cash, cash equivalents, prepaid expenses and other cur…

GRI Bio, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
GRI-DEBT-9884	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2023-12-31.
GRI-DEBT	Debt stack $58,000	90%	Market cache reports total debt of $58,000.
GRI-DEBT-9883	Warrants outstanding: 167	90%	xbrl warrant detail from xbrl 2025-12-31.

GRI Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for GRI Bio, Inc..

GRI Bio, Inc. Ownership

Holder	Name	Confidence	Evidence
GRI-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC	Geode Capital Management, LLC	90%	13F overlay lists Geode Capital Management, LLC as top holder; 6 tracked holders.

GRI Bio, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

GRI Bio, Inc. Supply Chain